FDA — authorised 26 June 1986
- Application: NDA018962
- Marketing authorisation holder: HOSPIRA
- Local brand name: MANGANESE CHLORIDE IN PLASTIC CONTAINER
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Manganese Chloride In Plastic Container in United States
FDA authorised Manganese Chloride In Plastic Container on 26 June 1986
Marketing authorisations
FDA — authorised 19 December 1997
- Marketing authorisation holder: BRACCO
- Status: approved
FDA — authorised 7 July 2025
- Application: ANDA217583
- Marketing authorisation holder: FRESENIUS KABI USA
- Local brand name: MANGANESE CHLORIDE
- Indication: INJECTABLE — INJECTION
- Status: approved
Manganese Chloride In Plastic Container in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is Manganese Chloride In Plastic Container approved in United States?
Yes. FDA authorised it on 26 June 1986; FDA authorised it on 19 December 1997; FDA authorised it on 7 July 2025.
Who is the marketing authorisation holder for Manganese Chloride In Plastic Container in United States?
HOSPIRA holds the US marketing authorisation.